Medication use in athletes selected for doping control at the Sydney Olympics (2000).
about
High prevalence of medication use in professional football tournaments including the World Cups between 2002 and 2014: a narrative review with a focus on NSAIDsThe use and abuse of painkillers in international soccer: data from 6 FIFA tournaments for female and youth players.Preventive Health Perspective in Sports Medicine: The Trend at the Use of Medications and Nutritional Supplements during 5 Years Period between 2003 and 2008 in FootballPotentially fatal new trend in performance enhancement: a cautionary note on nitrite.Prophylactic use of NSAIDs by athletes: a risk/benefit assessment.Dietary supplement usage and motivation in Brazilian road runners.Promoting functional foods as acceptable alternatives to doping: potential for information-based social marketing approach.Self-reported asthma and allergies in top athletes compared to the general population - results of the German part of the GA2LEN-Olympic study 2008.Anti-doping education and dietary supplementation practice in Korean elite university athletes.Use and abuse of medication during 2014 FIFA World Cup Brazil: a retrospective survey.Patterns of Nutrition and Dietary Supplements Use in Young Egyptian Athletes: A Community-Based Cross-Sectional Survey.Performance enhancement with supplements: incongruence between rationale and practice.Prevalence of Dietary Supplement Use by Athletes: Systematic Review and Meta-AnalysisThe age-gender-status profile of high performing athletes in the UK taking nutritional supplements: lessons for the futureThe continuing story of nutritional supplements and doping infractionsThe use of medication and nutritional supplements during FIFA World Cups 2002 and 2006.Nutritional supplements: prevalence of use and contamination with doping agents.National Athletic Trainers' Association position statement: Preparticipation physical examinations and disqualifying conditions.Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.Diclofenac pretreatment modulates exercise-induced inflammation in skeletal muscle of rats through the TLR4/NF-κB pathway.Doping and the Olympic games: the good, the bad, and the ugly.Medications and Nutritional Supplements in Athletes during the 2000, 2004, 2008, and 2012 FIFA Futsal World Cups.Nonsteroidal anti-inflammatory drug use and endurance during running in male long-distance runnersThe use of drugs and nutritional supplements in top-level track and field athletes.Gateway to doping? Supplement use in the context of preferred competitive situations, doping attitude, beliefs, and norms.Ibuprofen intake increases exercise time to exhaustion: A possible role for preventing exercise-induced fatigue.Ibuprofen alters human testicular physiology to produce a state of compensated hypogonadism.Asthma medication is increasingly prescribed for finnish olympic athletes--for a reason?Use of nutritional supplements by Danish elite athletes and fitness customers.Rhabdomyolysis/myoglobinemia and NSAID during 48 h ultra-endurance exercise (adventure racing).Use of Non-Steroidal Anti-Inflammatory Drugs among Participants in a Mountain Ultramarathon Event.Swimming
P2860
Q28082804-0F435F6F-EACE-4C58-AA1C-B39C99AA2247Q33375323-264D047E-78DF-473E-88D1-AED631A52779Q33974462-09E3454E-74FB-4F76-9CEA-40675B1D8BAAQ34019799-9A0D7272-AE60-4BBC-9D0B-0D02C6F14FF1Q34112547-A7512081-6609-46CF-BE68-75017FC47142Q34311299-B9CF347E-A47C-45E2-B821-A340FBFE5AEAQ34366422-34FC2149-9084-4C7C-B60D-E3A7AAA6DE7DQ34419309-53F4D297-41CD-406E-A8DD-9B8C08C00D43Q35233741-A43EBE0B-44F3-40A9-8568-34B326BA0959Q36053728-154960C6-5CC0-44F8-8311-4D6CA115CF42Q36104923-59CE9D08-F876-4E80-9990-04C530FFCE32Q36407054-BFE4DC7B-AD65-4420-B83D-60F0C3E769D3Q36420796-1DFBC9D5-F4AE-4229-B8EE-1DC0D7000474Q36489223-2152464B-79BD-4161-9A6F-8F74B02F5B52Q36767936-C0DC24AA-BDC2-412A-A923-F6721479C037Q36971117-01E499AA-3054-470D-873B-A731A9439767Q37350020-CD924F93-F7D7-4700-AADD-D6B212BE0DE2Q37566262-2C083900-40D2-438E-83C5-DA93D3C5AB03Q38093476-B9AC36F1-E92E-4411-BFE3-35DD1726E492Q38943513-28ABCE3B-DC28-4428-9F74-2F21832522E3Q39997439-5B2B90A2-5859-4FF0-92BC-256CBEE08522Q40313329-88FD2BF0-02C1-4F18-B6B6-D50AAEC5610FQ42410569-6E564158-2419-4CCF-84E5-09E60EB29E22Q43265363-403C5631-B019-4631-9C2A-80DB3330C133Q44149151-279704FC-BA1B-446E-97E8-18835F8751FBQ46636427-C7E88C91-0FB7-43E6-8391-0A678AA5FE07Q47195338-D7F42178-F267-48D4-892A-0EBEB562CD29Q47290992-45A3BAAF-200D-4CFF-8334-F7D301FE7260Q50571245-D25A527B-9949-4585-9D36-4F82A8A6D2E9Q51526430-3C09FDE1-0515-4BEB-B431-B499F1E97E2EQ55176205-C290848E-65F9-4335-8E0D-AA350D275CB2Q57577229-167910EF-06D0-4476-B478-AF1896070102
P2860
Medication use in athletes selected for doping control at the Sydney Olympics (2000).
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Medication use in athletes selected for doping control at the Sydney Olympics (2000).
@ast
Medication use in athletes selected for doping control at the Sydney Olympics (2000).
@en
type
label
Medication use in athletes selected for doping control at the Sydney Olympics (2000).
@ast
Medication use in athletes selected for doping control at the Sydney Olympics (2000).
@en
prefLabel
Medication use in athletes selected for doping control at the Sydney Olympics (2000).
@ast
Medication use in athletes selected for doping control at the Sydney Olympics (2000).
@en
P1476
Medication use in athletes selected for doping control at the Sydney Olympics (2000).
@en
P2093
Brian Corrigan
Rymantas Kazlauskas
P356
10.1097/00042752-200301000-00007
P577
2003-01-01T00:00:00Z